Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas

Summary

Primary objective- To determine efficacy of Avastin, 10 mg/kg every other week, in combination with standard 5-day temozolomide in terms of response rate. Secondary objective- To determine safety of Avastin \& Temozolomide in unresectable glioblastoma patients

Timeline

Start

2007-08

Primary completion

2012-05

Completion

2012-05

Drugs

Indications